Alterity Therapeutics (ATHE) has released an update.
Alterity Therapeutics Limited announced the application for the quotation of additional securities, specifically options expiring on August 31, 2026, with a total of 285,087,715 to be quoted as of April 15, 2024. These options were issued as part of a previous securities transaction and do not involve cash consideration, aligning with details from a prior announcement dated February 23, 2024. This move could potentially impact the company’s stock performance and investor interest.
For further insights into ATHE stock, check out TipRanks’ Stock Analysis page.
